|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Genmark Diagnostics, Inc. (GNMK) |
|
|
$24.04 0.00 (0.00%) as of 4:30 Tue 4/20
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
71,720,000 |
| Market
Cap: |
1.72(B) |
| Last
Volume: |
8,115 |
Avg
Vol: |
8,092 |
| 52
Week Range: |
$24.04 - $24.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ek John Frederick |
Chief Financial Officer |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,449 |
228,733 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
56,864 |
246,372 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-01-21 |
4 |
AS |
$14.93 |
$7,465 |
D/D |
(500) |
189,508 |
|
64% |
|
| Winkler Sarah Hollis |
VP, Human Resources |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,511 |
151,687 |
|
- |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
83,836 |
431,005 |
|
- |
|
| Obrien Scott Alexander |
SVP, Global Mktg & Intl Sales |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
151,603 |
|
- |
|
| Stier Eric |
SVP & General Counsel |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
77,240 |
307,277 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,185 |
291,084 |
|
- |
|
| Mendel Scott |
President & CEO |
• • – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
146,172 |
543,002 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-01-20 |
4 |
AS |
$15.00 |
$75,000 |
D/D |
(5,000) |
225,899 |
|
62% |
|
| Mendel Scott |
President & CEO |
• • – |
2021-01-19 |
4 |
AS |
$14.54 |
$727,000 |
I/I |
(50,000) |
115,491 |
|
64% |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-01-07 |
4 |
AS |
$16.99 |
$551,784 |
D/D |
(32,477) |
190,008 |
|
45% |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-01-07 |
4 |
OE |
$9.96 |
$376,665 |
D/D |
31,500 |
222,485 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-01-06 |
4 |
AS |
$16.00 |
$269,168 |
D/D |
(16,823) |
190,985 |
|
46% |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2020-12-24 |
4 |
AS |
$15.00 |
$7,500 |
D/D |
(500) |
207,808 |
|
59% |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2020-12-21 |
4 |
AS |
$15.00 |
$225,000 |
D/D |
(15,000) |
230,899 |
|
62% |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2020-12-10 |
4 |
AS |
$12.79 |
$6,395 |
D/D |
(500) |
208,308 |
|
78% |
|
| Shaw Christine |
VP, Assay Development |
• – – |
2020-12-07 |
4 |
S |
$13.97 |
$3,828 |
D/D |
(274) |
79,877 |
|
-70% |
|
| Obrien Scott Alexander |
SVP, Global Mktg & Intl Sales |
• – – |
2020-12-07 |
4 |
S |
$13.97 |
$10,366 |
D/D |
(742) |
134,937 |
|
-70% |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2020-11-27 |
4 |
AS |
$12.42 |
$6,210 |
D/D |
(500) |
208,186 |
|
85% |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2020-11-25 |
4 |
AS |
$12.72 |
$7,021 |
D/D |
(552) |
245,899 |
|
93% |
|
| Ek John Frederick |
Chief Financial Officer |
• – – |
2020-11-24 |
4 |
S |
$13.17 |
$18,675 |
D/D |
(1,418) |
178,284 |
|
-89% |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2020-11-24 |
4 |
S |
$13.17 |
$42,592 |
D/D |
(3,234) |
347,169 |
|
-89% |
|
| Shaw Christine |
VP, Assay Development |
• – – |
2020-11-24 |
4 |
S |
$13.17 |
$4,675 |
D/D |
(355) |
79,291 |
|
-89% |
|
| Stier Eric |
SVP & General Counsel |
• – – |
2020-11-24 |
4 |
S |
$13.17 |
$33,083 |
D/D |
(2,512) |
230,037 |
|
-89% |
|
1023 Records found
|
|
Page 5 of 41 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
